bupropion hydrochloride sr

Generic: bupropion hydrochloride sr

Labeler: directrx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride sr
Generic Name bupropion hydrochloride sr
Labeler directrx
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
DirectRx

Identifiers & Regulatory

Product NDC 72189-349
Product ID 72189-349_2c4c85cc-c2b6-ac98-e063-6294a90a973c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205794
Listing Expiration 2026-12-31
Marketing Start 2022-04-22

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189349
Hyphenated Format 72189-349

Supplemental Identifiers

RxCUI
993518
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride sr (source: ndc)
Generic Name bupropion hydrochloride sr (source: ndc)
Application Number ANDA205794 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-30)
  • 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-60)
source: ndc

Packages (2)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c4c85cc-c2b6-ac98-e063-6294a90a973c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["dd4041cd-00e4-d10f-e053-2a95a90a5945"], "manufacturer_name": ["DirectRx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-30)", "package_ndc": "72189-349-30", "marketing_start_date": "20220809"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-349-60)", "package_ndc": "72189-349-60", "marketing_start_date": "20220422"}], "brand_name": "BUPROPION HYDROCHLORIDE SR", "product_id": "72189-349_2c4c85cc-c2b6-ac98-e063-6294a90a973c", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72189-349", "generic_name": "BUPROPION HYDROCHLORIDE SR", "labeler_name": "DirectRx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20220422", "listing_expiration_date": "20261231"}